823 related articles for article (PubMed ID: 7244108)
21. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive.
Gussetti N; Pornaro E; Largajolli G; D'Elia R
Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895
[TBL] [Abstract][Full Text] [Related]
22. [Markers of viral replication (HBeAg and DNA polymerase activity) in chronic uremia, HBsAg positive, hemodialysis patients].
Dentico P; Buongiorno R; Angarano G; Monno L; Coppola S; Laddago V; Spinelli A; Pastore G
Boll Soc Ital Biol Sper; 1980 Nov; 56(21):2193-9. PubMed ID: 7213481
[TBL] [Abstract][Full Text] [Related]
23. [Hepatitis B: serological strategy and epidemiological aspects].
Penna R; Rabagliati AM
G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
[No Abstract] [Full Text] [Related]
24. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
26. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
[TBL] [Abstract][Full Text] [Related]
27. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
Calzia R; Ciravegna B; Navone C; Tolentino P
Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
[TBL] [Abstract][Full Text] [Related]
28. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
Babeş VT; Cepănaru S; Cepănaru R; Tănase M
Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
[No Abstract] [Full Text] [Related]
30. [Markers of type B viral hepatitis].
Brunello F; Emanuelli G; Camussi G
Minerva Med; 1979 Sep; 70(41):2791-800. PubMed ID: 386166
[TBL] [Abstract][Full Text] [Related]
31. [Comparative studies in detection methods of HBe-Ag, -Ab by MO and RIA and its clinical significance (author's transl)].
Matsumoto Y; Yagura H; Funahashi S; Kato M; Okuyama T; Masuzawa M; Matsuo S
Rinsho Byori; 1982 Mar; 30(3):350-4. PubMed ID: 6809988
[No Abstract] [Full Text] [Related]
32. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
[TBL] [Abstract][Full Text] [Related]
33. Anti-DNA, anti-HBc correlations with RIA-detected HBeAg and anti-HBe in chronic HBsAg carriers.
Villarejos VM; Andersen-Visoná K; Serra J; Frösner GG; Deinhardt F
J Med Virol; 1980; 5(4):265-71. PubMed ID: 7229619
[TBL] [Abstract][Full Text] [Related]
34. [The frequency of HBsAg in plasma donors, and the incidence of anti HBs, anti HBc, anti HBe and anti HAV in HBsAg negative plasma donors in Zagreb (author's transl)].
Grgicević D; Pistotnik M; Mikulicić V; Marchiotti I
Lijec Vjesn; 1980 Sep; 102(9):475-7. PubMed ID: 6264240
[No Abstract] [Full Text] [Related]
35. Distribution of hepatitis B e antigen (HBeAg) and anti-HBe in carriers with different levels of HBsAg.
Nath N; Fang CT; Fields HA; Doto IL; Maynard JE
J Med Virol; 1980; 6(2):179-84. PubMed ID: 7241093
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
[TBL] [Abstract][Full Text] [Related]
37. [Liver function tests: analysis of HB antigens and antibodies--HBs, HBc, and HBe antigens and antibodies].
Moritoh T; Saito K; Kasukawa R
Rinsho Byori; 1986 Jun; 34 Spec No 67():101-8. PubMed ID: 3534350
[No Abstract] [Full Text] [Related]
38. [Co-existence of HBeAg and anti-HBe in a subject with prolonged hepatitis B].
Cirelli A; Catania S
Clin Ter; 1981 Jul; 98(2):215-7. PubMed ID: 7261568
[No Abstract] [Full Text] [Related]
39. [HBs, HBc, and HBe antigens and their respective antibodies].
Akabane Y
Nihon Rinsho; 1979 Jun; Suppl():2407-8. PubMed ID: 491169
[No Abstract] [Full Text] [Related]
40. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
